Metabolism and toxicity of styrene in microsomal epoxide hydrolase-deficient mice

Journal of Toxicology and Environmental Health - Part A: Current Issues

Volumn 73, Issue 24, 2010, Pages 1689-1699

  Carlson, Gary P ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPOXIDE HYDROLASE; GLUTATHIONE; GLYCOL; IDITOL DEHYDROGENASE; LACTATE DEHYDROGENASE; MICROSOMAL EPOXIDE HYDROLASE; STYRENE; STYRENE OXIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DETOXIFICATION; ENZYME ACTIVITY; ENZYME DEFICIENCY; HISTOPATHOLOGY; LIVER TOXICITY; LUNG TOXICITY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; WILD TYPE;

ANIMALS; BRONCHI; BRONCHOALVEOLAR LAVAGE FLUID; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG-INDUCED LIVER INJURY; EPOXIDE HYDROLASES; EPOXY COMPOUNDS; GLUTATHIONE; L-IDITOL 2-DEHYDROGENASE; L-LACTATE DEHYDROGENASE; MALE; MICE; MICE, INBRED C57BL; MICROSOMES; STYRENE; TIME FACTORS;

MUS;

EID: 78249235318     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/15287394.2010.516240     Document Type: Article

References (51)

1. Arand, M., Cronin, A., Oesch, F., Mowbray, S. L., and Jones, T. A. 2003. The telltale structures of epoxide hydrolases. Drug Metab. Rev. 35:365-383.
2. Bauer, A. K., Faiola, B., Abernethy, D. J., Marchan, R., Pluta, L. J., Wong, V. A., Gonzalez, F. J., Butterworth, B. E., Borghoff, S. J., Everitt, J. I., and Recio, L. 2003. Male mice deficient in microsomal epoxide hydrolase are not susceptible to benzeneinduced toxicity. Toxicol. Sci. 72:201-209.
3. Bond, J. A. 1989. Review of the toxicology of styrene. Crit. Rev. Toxicol. 19:227-249.
4. Buschini, A., De Palma, G., Poli, P., Martino, A., Rossi, C., Mozzoni, P., Scotti, E., Buzio, L., Bergamaschi, E., and Mutti, A. 2003. Genetic polymorphisms of drugmetabolizing enzymes and styrene-induced DNA damage. Environ. Mol. Mutagen. 41:243-252.
5. Cajas-Salazar, N., Au, W. W., Zwishchenberger, J. B., Sierra-Torres, C. H., Salama, S. A., Alpard, S. K., and Tyring, S. K. 2003. Effect of epoxide hydrolase polymorphisms on chromosome aberrations and risk for lung cancer. Curr. Genet. Cytogenet. 145:97-102. (Pubitemid 36993738)
6. Carlson, G. P. 1997. Comparison of mouse strains for susceptibility to styrene-induced hepatotoxicity and pneumotoxicity. J. Toxicol. Environ. Health 51:177-187.
7. Carlson, G. P. 1998. Metabolism of styrene oxide to styrene glycol by mouse liver and lung. J. Toxicol. Environ. Health 53:19-27.
8. Erratum: 1999. J. Toxicol. Environ. Health 57:443.
9. Carlson, G. P. 2000. Metabolism of styrene oxide to styrene glycol in enriched mouse Clara cell preparations. J. Toxicol. Environ. Health A 61:709-717.
10. Carlson, G. P. 2010. Depletion by styrene of glutathione in plasma and bronchioalveolar lavage fluid of non-Swiss albino (NSA) mice. J. Toxicol. Environ. Health A 79:766-772.
11. Carlson, G. P., Ullman, M., Mantick, N., and Snyder, P. 2002. 4-Vinylphenol-induced pneumotoxicity and hepatotoxicity in mice. Toxicol. Pathol. 30:565-569.
12. Carlson, G. P., Turner, M., and Mantick, N. A. 2006. Effects of styrene and styrene oxide on glutathione-related antioxidant enzymes. Toxicology 227:217-226.
13. Cohen, J. T., Carlson, G., Charnley, G., Coggon, D., Delzell, E., Graham, J. D., Greim, H., Krewski, D., Medinsky, M., Monson, R., Paustenbach, D., Petersen, B., Rappaport, S., Rhomberg, L., Ryan, P. B., and Thompson, K. 2002. A comprehensive evaluation of the potential health risks associated with occupational and environmental exposure to styrene. J. Toxicol. Environ. Health B 5:1-263.
14. Cruzan, G., Carlson, G. P., Turner, M., and Mellert, W. 2005. Ring-oxidized metabolites of styrene contribute to styrene-induced Clara cell toxicity in mice. J. Toxicol. Environ. Health A 68:229-237.
15. Cruzan, G., Cushman, J. R., Andrews, L. S., Granville, G. C., Johnson, K. A., Hardy, C. J., Coombs, D. W., Mullins, P. A., and Brown, W. R. 1998. Chronic toxicity/oncogenicity study of styrene in CD rats by inhalation exposure for 104 weeks. Toxicol. Sci. 46:266-281.
16. Cruzan, G., Cushman, J. R., Andrews, L. S., Granville, G. C., Johnson, K. A., Bevan, C., Hardy, C. J., Coombs, D. W., Mullins, P. A., and Brown, W. R. 2001. Chronic toxicity/oncogenicity study of styrene in CD-1 mice by inhalation exposure for 104 weeks. J. Appl. Toxicol. 21:185-198.
17. Csanady, G. A., Mendrala, A. L., Nolan, R. J., and Filser, J. G. 1994. A physiological pharmacokinetic model for styrene and styrene-7, 8-oxide in mouse, rat and man. Arch. Toxicol. 68:143-157.
18. Decker, M., Arand, M., and Cronin, A. 2009. Mammalian epoxide hydrolases in xenobiotic metabolism and signalling. Arch. Toxicol. 83:297-318.
19. El Hadri, L., Chanas, B., and Ghanayem, B. I. 2005. Comparative metabolism of methacrylonitrile and acrylonitrile to cyanide using cytochrome P4502E1 and microsomal epoxide hydrolase-null mice. Toxicol. Appl. Pharmacol. 205:116-125.
20. Filser, J. G., Schwegler, U., Csanady, G. A., Greim, H., Kreuzer, P. E., and Kessler, W. 1993. Species-specific pharmacokinetics of styrene in rat and mouse. Arch. Toxicol. 67:517-530.
21. Gadberry, M. G., DeNicola, D. B., and Carlson, G. P. 1996. Pneumotoxicity and hepatotoxicity of styrene and styrene oxide. J. Toxicol. Environ. Health 48:273-294.
22. Gao, J., Lauer, F. T., Mitchell, L. A., and Burchiel, S. W. 2007. Microsomal epoxide hydrolase is required for 7, 12-dimethylbenz[a]anthracene (DMBA) - induced immunotoxicity in mice. Toxicol. Sci. 98:137-144.
23. Gao, J., Mitchell, L. A., Lauer, F. T., and Burchiel, S. W. 2008. P53 and ATM/ATR regulate 7, 12-dimethylbenz[a]antraceneinduced immunosuppression. Mol. Pharmacol. 73:137-146.
24. Garte, S., Taioli, E., Popov, T., Bolognesi, C., Farmer, P., and Merio, F. 2008. Genetic susceptibility to benzene toxicity in humans. J. Toxicol. Environ. Health A 71:1482-1489.
25. Gerlach, U. 1983. Sorbitol dehydrogenase. In Methods of enzymatic analysis, ed. H. U. Bergmeyer, 3rd ed., pp. 112-117. Weinheim: Verlag Chemie.
26. Haque, A. K., Au, W., Cajas-Salazar, N., Khan, S., Ginzel, A. W., Jones, D. V., Zwischenberger, J. B., and Xie, J. 2004. CYP2E1 polymorphism, cigarette smoking, p53 expression, and survival in non-small cell lung cancer. Appl. Immunohistochem. Mol. Morphol. 12:315-322.
27. Harvilchuck, J. A., Pu, X., Klaunig, J. E., and Carlson, G. P. 2009. Indicators of oxidative stress and apoptosis in mouse whole lung and Clara cells following exposure to styrene and its metabolites. Toxicology 264:171-178.
28. Harvilchuck, J. A., Zurbrugg, R. J., and Carlson, G. P. 2008. CC10 mRNA and protein expression in Clara cells of CD-1 mice following exposure to styrene or its metabolites styrene oxide or 4-vinylphenol. Toxicol. Lett. 183:28-35.
29. Herrero, M. E., Arand, M., Hengstler, J. G., and Oesch, F. 1997. Recombinant expression of human microsomal epoxide hydrolase protects V79 Chinese hamster cells from styrene oxide-but not from ethylene oxide-induced strand breaks. Environ. Mol. Mutagen. 30:429-439.
30. Hynes, D. E., DeNicola, D. B., and Carlson, G. P. 1999. Metabolism of styrene by mouse and rat isolated lung cells. Toxicol. Sci. 51:195-201.
31. IARC. 2002. Some industrial chemicals. IARC Monogr. Eval. Carcinogen. Risks Hum. 82:437-550.
32. Khedhaier, A., Hassen, E., Bouaouina, N., Gabbouj, S., Ahmen, S. B., and Chouchane, L. 2008. Implication of xenobiotic metabolizing enzyme gene (CYP2E1, CYP2C19, CYP2D6, mEH and NAT2) polymorphisms in breast carcinoma. BMC Cancer 8:109.
33. Lee, W. J., Brennan, P., Boffetta, P., London, S. J., Benhamou, S., Rannug, A., To-Figueras, J., Ingelman-Sundberg, M., Shields, P., Gaspari, L., and Taioli, E. 2002. Microsomal epoxide hydrolase polymorphisms and lung cancer risk: A quantitative review. Biomarkers 7:230-241. (Pubitemid 34678838)
34. Meszka-Jordan, A., Mahlapuu, R., Soomets, U., and Carlson, G. P. 2009. Oxidative stress due to (R)-styrene oxide exposure and the role of antioxidants in non-Swiss albino (NSA) mice. J. Toxicol. Environ. Health A 72:642-650.
35. Miller, R. R., Newhook, R., and Poole, A. 1994. Styrene production, use, and human exposure. Crit. Rev. Toxicol. 24 (suppl. 1): S1-S10.
36. Mittal, R. D., and Srivastava, D. L. 2007. Cytochrome P4501A1 and microsomal epoxide hydrolase gene polymorphisms; Gene-environment interaction and risk of prostate cancer. DNA Cell Biol. 26:791-798.
37. Miyata, M., Kudo, G., Lee, Y.-H., Yang, T. J., Gelboin, H. V., Fernandez-Salguero, P., Kimura, S., and Gonzalez, F. J. 1999. Targeted disruption of the microsomal epoxide hydrolase gene. Microsomal epoxide hydrolase is required for the carcinogenic activity of 7, 12-dimethylbenz[a] anthracene. J. Biol. Chem. 274:23963-23968.
38. Morgan, D. L., Mahler, J. F., O'Connor, R. W., Price, H. C., and Adkins, B. 1993. Styrene inhalation toxicity studies in mice. I. Hepatotoxicity in B6C3F1 mice. Fundam. Appl. Toxicol. 20:325-335.
39. Morisseau, C., and Hammock, B. D. 2005. Epoxide hydolases: Mechanisms, inhibitor designs and biological roles. Annu. Rev. Pharmacol. Toxicol. 45:301-333.
40. Oesch, F., Herrero, M. E., Hengstler, J. G., Lohmann, M., and Arand, A. 2000. Metabolic detoxification: Implications for thresholds. Toxicol. Pathol. 28:382-387.
41. Ota, K., and Hammock, B. D. 1980. Cytosolic and microsomal epoxide hydrolases: Differential properties in mammalian liver. Science 207:1479-1481.
42. Ramsey, J. C., and Andersen, M. E. 1984. A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans. Toxicol. Appl. Pharmacol. 73:159-175.
43. Recio, L., Bauer, A., and Faiola, B. 2005. Use of genetically modified mouse models to assess pathways of benzene-induced bone marrow cytotoxicity and genotoxicity. Chem. Biol. Interact. 153-154:159-164.
44. Rueff, J., Teixeira, J. P., Santos, L. S., and Gaspar, J. F. 2009. Genetic effects and biotoxicity monitoring of occupational styrene exposure. Clin. Chim. Acta 399:8-23.
45. Sarangapani, R., Teeguarden, J. G., Cruzan, G., Clewell, H. J., and Andersen, M. E. 2002. Physiologically based pharmacokinetic modeling of styrene and styrene oxide respiratory-tract dosimetry in rodents and humans. Inhal. Toxicol. 14:789-834.
46. Sumner, S. J., and Fennell, T. R. 1994. Review of the metabolic fate of styrene. Crit. Rev. Toxicol. 24 (suppl.): 11-33.
47. Teixeira, J. P., Gaspar, J., Roma-Torres, J., Silva, S., Costa, C., Roach, J., Mayan, O., Rueff, J., and Farmer, P. B. 2007. Styrene-oxide N-terminal valine haemoglobin adducts in reinforced plastic workers; Possible influence of genetic polymorphism of drug-metabolizing enzymes. Toxicology 237:58-64.
48. Turner, M., Mantick, N. A., and Carlson, G. P. 2005. Comparison of the depletion of glutathione in mouse liver and lung following administration of styrene and its metabolites styrene oxide and 4-vinylphenol. Toxicology 206:383-388.
49. Vassault, A. 1983. Lactate dehydrogenase. UV-method with pyruvate and NADH. In Methods of enzymatic analysis, ed. H. U. Bergmeyer, 3rd ed., pp. 118-125. Weinheim: Verlag Chemie.
50. Vodicka, P., Kumar, R., Stetina, R., Musak, L., Soucek, P., Haufroid, V., Sasiadek, M., Vodickova, L., Naccarati, A., Sedikova, J., Sanyal, S., Kuricova, M., Brsiak, V., Norppa, H., Buchancova, J., and Hemminki, K. 2004. Markers of individual susceptibility and DNA repair rate in workers exposed to xenobiotics in a tire plant. Environ. Mol. Mutagen. 44:283-292.
51. Wickliffe, J. K., Ammenheuser, M. M., Salazar, J. J., Abdel-Rahman, S. Z., Hastings-Smith, D. A., Postlethwait, E. M., Lloyd, R. S., and Ward, J. B. 2003. A model of sensitivity: 1, 3-Butadiene increases mutant frequencies and genomic damage in mice lacking a functional microsomal epoxide hydrolase gene. Environ. Mol. Mutagen. 42:106-110.